Company news

AngioDynamics, Inc. news in 2023

AngioDynamics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024

December 6, 2023

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism

December 6, 2023

AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance

October 3, 2023

AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023

September 11, 2023

AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation

August 14, 2023

AngioDynamics Completes Enrollment for PRESERVE Clinical Study

August 2, 2023

AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference

July 30, 2023

AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors

July 23, 2023

AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance

July 11, 2023

AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023

June 19, 2023

AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million

June 7, 2023

AngioDynamics to Present at the Needham Virtual Healthcare Conference

April 10, 2023

AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance

March 29, 2023

AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023

March 12, 2023

AngioDynamics to Participate in Three Investor Conferences in March

February 27, 2023

AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance

January 4, 2023

Calls in 2023

Decks in 2023